Sanofi appoints Peter Guenter, Senior Vice President, Europe

Paris, France - - Sanofi (EURONEXT : SAN ; NYSE : SNY) is pleased to announce today the appointment of Peter Guenter, as Senior Vice President, Europe, effective July 15, 2011. He will report to Hanspeter Spek, President, Global Operations and will join the Management Committee.

Peter Guenter, who is currently General Manager for the Multi-Country-Organisation for Germany, Switzerland and Austria, will succeed Belen Garijo, who will leave the Group and take a global leadership role in another Pharmaceutical Company. Hanspeter Spek, President, Global Operations, Sanofi declared: “I would like to sincerely express my gratitude to Belen for her dedication to the company over the last 15 years. With her combination of experience, skill, passion and commitment, Belen was able to drive the transformation of Sanofi in Europe over the past several years. We wish her all the best for her new professional opportunity.”

“The depth of knowledge and experience Peter gained through his previous management roles in Germany and in Europe, as well as his general business acumen make him ideally suited to lead Sanofi’s operations in Europe.”

Peter Guenter holds a Masters Degree in Physical Education at the Faculty of Medicine and Health Sciences, University of Ghent, Belgium. He started his career in Sales at SmithKline in 1986. He joined the Group in 1995 and held various positions in France, Europe and Global Marketing. In 2000, he was appointed General Manager Belgium and then Vice President for Eastern Europe, Northern Europe & Scandinavia. In 2008, he was appointed General Manager, Commercial Operations for Germany, and since 2011, he has been General Manager for the Multi Country- Organisation for Germany, Switzerland and Austria.

About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).